GlassScriptPhysician profile
Ryan T Hayes
NPI 1104208008
$2,267.42
in general payments reported to CMS, 2019-2025
20 companies · $653 in 2025
The $653 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2021: $161 · 2022: $215 · 2023: $233 · 2024: $552 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $641.16 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $348.33 | 2019-2024 | Clareon, Hydrus Microstent, Centurion |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $213.60 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $153.97 | 2024-2025 | Xdemvy |
| New World Medical,INC. | $128.31 | 2022-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Aerie Pharmaceuticals, INC. | $125.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $114.08 | 2019 | |
| Novartis Pharmaceuticals Corporation | $100.18 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $92.13 | 2023 | Tecnis Iol, Tecnis Iol |
| Biotissue Holdings INC. | $69.00 | 2022-2025 | |
| Oyster Point Pharma, INC. | $46.05 | 2022-2023 | Tyrvaya |
| Dompe US, INC. | $44.25 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $40.82 | 2022-2025 | Miebo, Xiidra |
| Rxsight INC | $35.07 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Glaukos Corporation | $32.20 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $18.64 | 2022 | |
| Thea Pharma INC. | $18.29 | 2025 | Iyuzeh |
| Shire North American Group INC | $17.03 | 2019 | |
| Abbvie INC. | $16.20 | 2025 | |
| Horizon Therapeutics Plc | $13.11 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.